Neurogene Inc.
NGNE
$15.00
$1.9715.12%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -19.51M | -20.22M | -18.49M | -16.92M | 2.38M |
| Total Depreciation and Amortization | 798.00K | 807.00K | 817.00K | 825.00K | 828.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.12M | 1.28M | 2.66M | 1.20M | -15.93M |
| Change in Net Operating Assets | -896.00K | 2.56M | -879.00K | -6.75M | -4.25M |
| Cash from Operations | -17.50M | -15.56M | -15.89M | -21.65M | -16.97M |
| Capital Expenditure | -116.00K | -167.00K | -460.00K | -65.00K | -128.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 20.96M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -102.50M | -28.80M | -23.15M | 30.00M | 5.00M |
| Cash from Investing | -102.62M | -28.97M | -23.61M | 29.94M | 25.83M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -13.00K | -12.00K | -16.00K | -11.00K | -8.00K |
| Issuance of Common Stock | 489.00K | 143.00K | 415.00K | 629.00K | 1.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 189.59M | 0.00 | 0.00 | -7.14M | 94.30M |
| Cash from Financing | 190.07M | 131.00K | 399.00K | -6.52M | 94.30M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 69.95M | -44.40M | -39.11M | 1.76M | 103.16M |